28470100|t|Dexmedetomidine Effect on Emergence Agitation and Delirium in Children Undergoing Laparoscopic Hernia Repair: a Preliminary Study
28470100|a|Objective To evaluate the safety and efficacy of dexmedetomidine (Dex) to prevent emergence agitation (EA) and delirium (ED) in children undergoing laparoscopic hernia repair under general anesthesia. Methods 100 children (1-5 years, 10-25 kg) were randomized into four groups: controls (saline) and intravenous Dex at 0.25, 0.5, and 1.0 µg/kg (D1, D2, D3, respectively). Dex / saline infusion was started following anesthesia. EA and ED were evaluated on a 5-point scale. Results For the C, D1, D2, and D3 groups, respectively, EA frequencies were 45.8%, 30.4%, 12%, 4%; ED frequencies 29.1%, 13%, 4%, 4%; CHIPPS scores 8, 6, 3, 3; sevoflurane doses from 13.2 ± 3.4 (controls) to 9.4 ± 3.5 ml (D3). Intervals until mask removal / spontaneous eye opening were significantly longer for D2 and D3 than controls. PACU stay was longer for D3. Conclusions There was significantly less postoperative EA and pain, with less sevoflurane required, using Dex.
28470100	0	15	Dexmedetomidine	T109,T121	C0113293
28470100	16	22	Effect	T080	C1280500
28470100	26	45	Emergence Agitation	T048	C0920253
28470100	50	58	Delirium	T048	C0011206
28470100	62	70	Children	T100	C0008059
28470100	82	108	Laparoscopic Hernia Repair	T061	C2111384
28470100	112	123	Preliminary	T079	C0439611
28470100	124	129	Study	T062	C2603343
28470100	156	162	safety	T080	C0678800
28470100	167	175	efficacy	T080	C1280519
28470100	179	194	dexmedetomidine	T109,T121	C0113293
28470100	196	199	Dex	T109,T121	C0113293
28470100	212	231	emergence agitation	T048	C0920253
28470100	233	235	EA	T048	C0920253
28470100	241	249	delirium	T048	C0011206
28470100	251	253	ED	T048	C0011206
28470100	258	266	children	T100	C0008059
28470100	278	304	laparoscopic hernia repair	T061	C2111384
28470100	311	329	general anesthesia	T061	C0002915
28470100	343	351	children	T100	C0008059
28470100	357	362	years	T079	C0439234
28470100	379	389	randomized	T062	C0034656
28470100	400	406	groups	T078	C0441833
28470100	408	416	controls	T096	C0009932
28470100	418	424	saline	T167	C0036082
28470100	430	441	intravenous	T082	C0348016
28470100	442	445	Dex	T109,T121	C0113293
28470100	475	477	D1	T081	C0178602
28470100	479	481	D2	T081	C0178602
28470100	483	485	D3	T081	C0178602
28470100	502	505	Dex	T109,T121	C0113293
28470100	508	514	saline	T167	C0036082
28470100	515	523	infusion	T061	C0574032
28470100	546	556	anesthesia	T121	C4049933
28470100	558	560	EA	T048	C0920253
28470100	565	567	ED	T048	C0011206
28470100	588	601	5-point scale	T170	C0282574
28470100	619	620	C	T096	C0009932
28470100	622	624	D1	T081	C0178602
28470100	626	628	D2	T081	C0178602
28470100	634	636	D3	T081	C0178602
28470100	637	643	groups	T078	C0441833
28470100	659	661	EA	T048	C0920253
28470100	662	673	frequencies	T079	C0439603
28470100	702	704	ED	T048	C0011206
28470100	705	716	frequencies	T079	C0439603
28470100	737	743	CHIPPS	T170	C1504479
28470100	744	750	scores	T081	C0449820
28470100	763	774	sevoflurane	T109,T121	C0074414
28470100	775	780	doses	T081	C0178602
28470100	798	806	controls	T096	C0009932
28470100	825	827	D3	T081	C0178602
28470100	830	839	Intervals	T079	C1272706
28470100	846	850	mask	T074	C0024861
28470100	851	858	removal	T052	C1883720
28470100	861	884	spontaneous eye opening	T082	C1882151
28470100	904	910	longer	T080	C0205166
28470100	915	917	D2	T081	C0178602
28470100	922	924	D3	T081	C0178602
28470100	930	938	controls	T096	C0009932
28470100	940	944	PACU	T073,T093	C0034871
28470100	945	949	stay	T079	C3489408
28470100	954	960	longer	T080	C0205166
28470100	965	967	D3	T081	C0178602
28470100	1010	1023	postoperative	T079	C0032790
28470100	1024	1026	EA	T048	C0920253
28470100	1031	1035	pain	T184	C0030201
28470100	1047	1058	sevoflurane	T109,T121	C0074414
28470100	1075	1078	Dex	T109,T121	C0113293